Sara Gandini

European Institute of Oncology

Papers

2

Total Citations

13

H-Index

2

About

Sara Gandini is a leading head and neck surgeon whose research focuses on optimizing treatment strategies for HPV-positive oropharyngeal cancer, particularly through the integration of transoral robotic surgery (TORS). Her major contributions include providing real-world evidence comparing upfront TORS versus intensity-modulated radiation therapy (IMRT) for locally advanced HPV-positive oropharyngeal cancer, a study that has garnered 9 citations and offers critical insights into oncologic and functional outcomes. Additionally, her work on soft tissue necrosis in patients undergoing TORS followed by postoperative radiotherapy (PORT) has been instrumental in quantifying toxicity profiles, with 4 citations highlighting its clinical relevance. Gandini’s research directly addresses the balance between curative intent and quality of life, making her a key figure in advancing minimally invasive surgical approaches. Her findings from a tertiary comprehensive cancer center underscore the importance of personalized treatment pathways, influencing both surgical and radiation oncology practices. With a focus on real-world data, Gandini’s contributions are shaping the future of head and neck cancer care, offering valuable guidance for clinicians and researchers alike.

Research Focus

Key Achievements

2
H-Index
2
Papers
13
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Upfront transoral robotic surgery (TORS) versus intensity-modulated radiation therapy (IMRT) in HPV-positive oropharyngeal cancer: real-world data from a tertiary comprehensive cancer centre
9 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 24
🏛 Institutions: European Institute of Oncology

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago